Obesity as a risk factor for anthracyclines and trastuzumab cardiotoxicity in breast cancer: A systematic review and meta-analysis Review uri icon

Overview

MeSH Major

  • Anthracyclines
  • Antibiotics, Antineoplastic
  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Heart Diseases
  • Obesity
  • Trastuzumab

abstract

  • Our findings in a largely unadjusted analysis suggest that overweight and obesity are risk factors for cardiotoxicity from anthracyclines and sequential anthracyclines and trastuzumab.

publication date

  • September 10, 2016

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC5569689

Digital Object Identifier (DOI)

  • 10.1200/JCO.2016.67.4846

PubMed ID

  • 27458291

Additional Document Info

start page

  • 3157

end page

  • 65

volume

  • 34

number

  • 26